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OBJECTIVE — To assess the associations between measures of adiposity and sex hormone–
binding globulin (SHBG) and to evaluate whether such associations differ by race.
RESEARCH DESIGN AND METHODS — Adiposity was measured by anthropometry
and dual-energy X-ray absorptiometry among women (146 white, 50 black, and 25 Asian) aged
18–44 years in the BioCycle study. SHBG was repeatedly measured over one to two menstrual
cycles. The ratio of trunkal to leg fat (T/L) was used to assess upper to lower body adiposity.
RESULTS — Amongwhites,alladipositymeasuresweresigniﬁcantlyandinverselyassociated
with SHBG. Among blacks, BMI ( 0.032), waist circumference ( 0.016), and T/L
( 0.033) were signiﬁcantly associated with SHBG, whereas total and trunkal fat were not
(P interaction with race 0.04). Among Asians, measures of central and upper body fat were
signiﬁcantly associated with SHBG (e.g., T/L,  0.84) but not BMI.
CONCLUSIONS — Associations between SHBG and adiposity differ by race among pre-
menopausal women.
Diabetes Care 33:2274–2276, 2010
R
acial differences in type 2 diabetes
risk have been incompletely ac-
counted for by differences in adipos-
ity, partly because of disparities in the
relationships between adiposity and other
risk factors such as insulin and lipid levels
(1). Obesity is associated with a decreased
level of sex hormone–binding globulin
(SHBG),whichisassociatedwiththedevel-
opment of type 2 diabetes (2). However,
dataontheassociationsbetweenSHBGand
adiposity in premenopausal women are
sparse, and it is unknown whether such as-
sociations differ by race/ethnicity.
RESEARCH DESIGN AND
METHODS— The BioCycle study,
originally designed to investigate the as-
sociation between endogenous sex hor-
mones and oxidative stress, followed 259
premenopausal women aged 18–44
years for one to two menstrual cycles,
with up to eight clinic visits per cycle,
timed using fertility monitors (3,4). The
inclusion/exclusion criteria have been
published (4). Over 94% of the partici-
pants attended at least seven visits. For
theseanalyses,weexcludedwomenmiss-
ing body composition measurements
(n  11), leaving 146 white, 50 black, 25
Asian, and 25 women of other race. The
University of Buffalo Health Sciences In-
stitutional Review Board approved the
study. All women provided informed
consent.
Demographic characteristics and life-
style information were self-reported (4).
Anthropometry was measured by trained
personnel. A dual-energy X-ray absorpti-
ometry scan (Hologic, Waltham, MA), as
previously validated in other studies
(5,6), was performed to measure total
body fat (%BF) and total trunkal fat
(%TF). Trunkal fat mass was divided by
legfatmasstoassessupper-to-lowerbody
fat ratio (T/L). Fasting estradiol, SHBG,
insulin, and glucose had interassay coef-
ﬁcients of variation of 10, 10, 8,
and 3%, respectively (4). Insulin resis-
tance and -cell function were calculated
basedonthehomeostasismodel(HOMA)
(7).
Associations between all repeated
measures of SHBG and adiposity mea-
suresmeasuredatasingletimepointwere
estimatedusingmixedmodelswitharan-
dom intercept, which accounted for re-
peated measures and adjusted for age and
cycle. In additional models, we adjusted
for caloric intake, total physical activity,
and repeated measures of estradiol (E2),
and HOMA-IR (insulin resistance). To
test for interaction, we included a cross-
product term between each adiposity
measure and race. Spearman correlations
were calculated using values from the fol-
licular phase visit of cycle 1. Analyses
were performed using SAS 9.1 (SAS Insti-
tute, Cary, NC).
RESULTS— A total of 33% of the
women were overweight or obese (BMI
25 kg/m
2) (supplemental Table A1,
available in an online appendix at http://
care.diabetesjournals.org/cgi/content/
full/dc10-0670/DC1). Black women
had higher ovulatory estradiol, insulin,
HOMA-IR, and HOMA- levels than
other women. Differences remained after
adjusting for age and BMI or %BF (P 
0.01). Other hormones did not differ sig-
niﬁcantly by race.
SHBG in white women were consis-
tently inversely associated with adiposity
(Table 1). Results from mixed models
show all adiposity measures except hip
circumference were also inversely associ-
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However, the Spearman correlations and
signiﬁcantinteractionssuggestweakeras-
sociations between adiposity and SHBG
among them.
%BF and %TF among black women
were not signiﬁcantly associated with
SHBG(Table1).Adjustingforage,caloric
intake, physical activity, estradiol, and
HOMA-IR did not eliminate racial differ-
ences. T/L was associated with SHBG in
both blacks ( 0.33, P  0.003) and
whites ( 0.36, P  0.001), as were
BMI and waist circumference. Among
Asians, %BF was not associated with
SHBG, whereas waist ( 0.022) and
T/L ( 0.85) remained associated.
CONCLUSIONS— Among healthy
premenopausal women, SHBG was in-
versely associated with measurements of
body fat in whites. In blacks, correlations
of SHBG with adiposity were weak, with
thestrongestinverseassociationobserved
with upper to lower body fat ratio (i.e.,
T/L). Among Asians, the strongest inverse
association was with central and upper
adiposity (by T/L or waist).
Upper or total body adiposity do not
carry the same type 2 diabetes–inducing
“toxic” effects among women of different
race/ethnicity (1,8). It has been observed
that despite occasions of similar adipos-
ity, blacks have higher insulin levels than
whites, whether during fasting or in re-
sponsetoaglucosechallenge(9).Herewe
found the same phenomena with fasting
insulin and HOMA-IR. These differences
could be through the mechanism of
greater -cell activity among blacks in
compensationofhigherinsulinresistance
(7), as conﬁrmed here by HOMA-.
We add to this body of research the
racial differences seen between the asso-
ciations of SHBG, a type 2 diabetes risk
factor (2), and adiposity. Despite the
black-whitedifferenceininsulinemiaand
thedocumentedrelationshipbetweenhy-
perinsulinemia and SHBG (10,11), we
foundnosigniﬁcantdifferenceinlevelsof
SHBGbyrace.Studiesareinconsistenton
absolute differences in SHBG by race;
blacks have been observed to have higher
SHBG than whites in one study (1) and
lower levels in others (12–14). Despite
the lack of racial difference in absolute
SHBGlevelsinourstudy,measuresofad-
iposity in blacks were not as strongly cor-
related with SHBG as in whites. These
observations agree with previous investi-
gationsamongpremenopausal(1,12)and
postmenopausal women (15). However,
unlike previous studies, we were able to
adjust for estradiol and insulin and found
that these hormones do not account for
the racial differences. Studies among
Asian women are lacking, but our obser-
vation that central adiposity was strongly
inversely associated with SHBG levels
here requires replication in a larger
sample.
Our study was limited by different
sample sizes of racial groups, which af-
fected the precision of estimates and may
have led to nonsigniﬁcant associations
among minority groups. However, using
mixedmodelsonrepeatedmeasurements
decreased the effects of intra-individual
variability on results and helped to in-
creasepower.Wealsolackedinformation
on testosterone. However, previous in-
vestigation observed that SHBG is associ-
ated with adiposity independent of
testosterone (10). We could not deter-
mine directionality of the association be-
tween adiposity and SHBG because of
singlemeasuresofadiposity.Thestrength
of our study comes from a wealth of in-
formation including measures of adipos-
ity by dual-energy X-ray absorptiometry
and repeated measures of hormone levels
timed to capture cycle phase.
These ﬁndings suggest that despite
having similar levels of SHBG, racial dif-
ferences exist for the relationships be-
tween SHBG and adiposity among
premenopausal women, adding to the ev-
idence that the metabolic and reproduc-
tive inﬂuence of adipose tissue may differ
by race.
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